Trofinetide (2 brand names, 2 dosage forms, 1 route)
Available dosage forms: FOR SOLUTION, SOLUTION.
Routes of administration: ORAL.
Brand Names
- DAYBUE
- DAYBUE STIX
Indications and Usage
DAYBUE and DAYBUE STIX are indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
Contraindications
None.
Adverse Reactions
The following clinically significant adverse reactions are described elsewhere in labeling: Diarrhea [see Warnings and Precautions (5.1)] Weight Loss [see Warnings and Precautions (5.2)] Vomiting [see Warnings and Precautions (5.3)]
Mechanism of Action
The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown.
⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.